We are live on ! Find out more
CYTK icon

Cytokinetics

132 hedge funds and large institutions have $575M invested in Cytokinetics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $9.37M | Put options by funds: $6.62M

36% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 39

24% more capital invested

Capital invested by funds: $465M → $575M (+$111M)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 136132 (-4)

4.93% less ownership

Funds ownership: 78.84%73.92% (-4.9%)

Holders
132
Holders Change
-4
Holders Change %
-2.94%
% of All Funds
3.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
53
Reduced
39
Closed
20
Calls
$9.37M
Puts
$6.62M
Net Calls
+$2.75M
Net Calls Change
-$134K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$964K -$97.7K -7,152 -10%
NFA
52
Nationwide Fund Advisors
Ohio
$963K
Canada Life
53
Canada Life
Manitoba, Canada
$959K -$1.32K -97 -0.1%
Group One Trading
54
Group One Trading
Illinois
$958K +$530K +38,797 +142%
Swiss National Bank
55
Swiss National Bank
Switzerland
$945K +$104K +7,600 +13%
Los Angeles Capital Management
56
Los Angeles Capital Management
California
$799K +$752K +55,087 New
CS
57
Credit Suisse
Switzerland
$784K +$132K +9,688 +22%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$761K
Comerica Bank
59
Comerica Bank
Texas
$737K +$70.9K +5,192 +11%
Wells Fargo
60
Wells Fargo
California
$733K +$226K +16,555 +49%
Two Sigma Advisers
61
Two Sigma Advisers
New York
$667K +$113K +8,300 +22%
SAM
62
Shell Asset Management
Netherlands
$607K -$13.7K -1,000 -2%
PAM
63
Panagora Asset Management
Massachusetts
$601K +$566K +41,436 New
State of Tennessee, Department of Treasury
64
State of Tennessee, Department of Treasury
Tennessee
$593K +$6.78K +496 +1%
GIP
65
Granite Investment Partners
California
$576K +$543K +39,732 New
PPA
66
Parametric Portfolio Associates
Washington
$538K +$192K +14,072 +61%
TPSF
67
Texas Permanent School Fund
Texas
$534K +$41.9K +3,067 +9%
PCM
68
Prelude Capital Management
New York
$519K +$155K +11,322 +46%
ProShare Advisors
69
ProShare Advisors
Maryland
$494K +$89.7K +6,564 +24%
AIG
70
American International Group
New York
$493K +$30.9K +2,265 +7%
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$473K -$1.27K -93 -0.3%
Public Sector Pension Investment Board (PSP Investments)
72
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$467K +$98.9K +7,241 +29%
Two Sigma Investments
73
Two Sigma Investments
New York
$461K -$1.18M -86,083 -73%
Thrivent Financial for Lutherans
74
Thrivent Financial for Lutherans
Minnesota
$444K +$33.3K +2,440 +9%
State of Wisconsin Investment Board
75
State of Wisconsin Investment Board
Wisconsin
$435K

CYTK Hedge Fund Activity: Q3 2017 in Review

132 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2017, worth a combined $575M — up 24% from $465M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of CYTK and 19 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 53 added.

The largest buyer was Citadel Advisors, adding an estimated $15.7M. The largest seller was BVF Inc, cutting an estimated $10.2M.

  • 132 institutional investors held Cytokinetics (CYTK) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $575M of Cytokinetics stock for Q3 2017, up 24% quarter-over-quarter.
  • 19 funds opened new Cytokinetics positions in Q3 2017 and 20 closed out, a net change of -1 holder.
  • The largest Cytokinetics buyer in Q3 2017 was Citadel Advisors, an estimated $15.7M added.
  • The largest Cytokinetics seller in Q3 2017 was BVF Inc, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2017.